Ohmura SI, Naniwa T, Tamechika SY, Miyamoto T, Shichi D, Kazawa N, Iwagaitsu S, Maeda S,Wada JI, Niimi A. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study. J Infect Chemother. 2019 Apr;25(4):253-261. doi: 10.1016/j.jiac.2018.11.014. Epub 2019 Jan 12. PMID: 30642768.
Ohmura SI, Homma Y, Masui T, Miyamoto T. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study. Intern Med. 2021 Sep 11. doi:10.2169/internalmedicine.8205-21. Epub ahead of print. PMID: 34511571.
Ohmura SI, Tamechika SY, Miyamoto T, Kunieda K, Naniwa T. Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis. Int J Rheum Dis. 2022 Jun 9. doi: 10.1111/1756-185X.14365. Epub ahead of print. PMID: 35678075.
Ohmura SI, Matsui H, Miyamoto T, Shichi D, Masui T, Ichijo K, Homma Y, Fujioka H, Nagai T, Nakashima K. Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics. Respir Investig. 2024 Mar 6;62(3):377-383. doi: 10.1016/j.resinv.2024.02.015. Epub ahead of print. PMID: 38452442.
Yukishima T, Ebina K, Etani Y, Noguchi T, Ohmura SI, Nakata K, Okada S,Kobayakawa T. Impact of switching from bisphosphonates to denosumab,eriparatide, or romosozumab in patients with postmenopausal osteoporosis: acase-control study. Osteoporos Int. 2025 Mar;36(3):531-538. doi:10.1007/s00198-025-07386-4. Epub 2025 Jan 16. PMID: 39821342; PMCID:PMC11882683.
Ohmura SI, Masui T, Yukishima T, Ohkubo Y, Yonezawa H, Miyamoto T.Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in patients with systemic rheumatic diseases receiving moderate-to high-dose glucocorticoids. Respir Investig. 2024 Nov;62(6):1195-1201. doi: 10.1016/j.resinv.2024.10.007. Epub 2024 Oct 22. PMID:39442269.
Ohmura SI, Sato K, Nishimura R, Miyamoto T. Long-Term Dysphagia Severity in Patients With Idiopathic Inflammatory Myopathy: A Single-Center Retrospective Study. Cureus. 2024 Oct 18;16(10):e71821. doi: 10.7759/cureus.71821. PMID: 39429985; PMCID: PMC11489808.
Yukishima T, Nakamura Y, Ohmura SI, Kobayakawa T. Effectiveness of baricitinib versus sarilumab on disease activity in patients with RA: a propensity score matching study. Rheumatol Adv Pract. 2025 Jan 10;9(1):rkaf006. doi: 10.1093/rap/rkaf006. PMID: 39959132; PMCID: PMC11829163.
Case report
Ohmura SI, Uehara K, Yamabe T, Tamechika S, Maeda S, Naniwa T. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide. Mod Rheumatol Case Rep. 2020 Jul;4(2):202-207. doi: 10.1080/24725625.2020.1741073. Epub 2020 Mar 23. PMID: 33086994.
Ohmura SI, Yamabe T, Naniwa T. Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies. Mod Rheumatol Case Rep. 2021 Jan;5(1):76-81. doi:10.1080/24725625.2020.1816674. Epub 2020 Sep 14. PMID:32867615.
Ohmura SI, Ishihara R, Mitsui A, Otsuki Y, Miyamoto T. A Fatal Case of Concurrent Disseminated Tuberculosis, Pneumocystis Pneumonia, and Bacterial Septic Shock in a Patient with Rheumatoid Arthritis Receiving Methotrexate, Glucocorticoid, and Tocilizumab: An Autopsy Report. Case Rep Rheumatol. 2021 Sep 7;2021:7842049. doi: 10.1155/2021/7842049. PMID: 34532148; PMCID: PMC8440108.
Ohmura SI, Homma Y, Hanai S, Miyamoto T. Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection. Intern Med. 2022 Feb 1;61(3):433-438. doi: 10.2169/internalmedicine.8643-21. Epub 2021 Nov 20. PMID: 34803106.
Ohmura SI, Hanai S, Ishihara R, Ohkubo Y, Miyamoto T. A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine. J Eur Acad Dermatol Venereol. 2022 Feb 17. doi: 10.1111/jdv.18013. Epub ahead of print. PMID: 35176180.
Ohmura SI, Homma Y, Hanai S, Otsuki Y, Miyamoto T. Successful Switching Treatment of Adalimumab for Refractory Pyoderma Gangrenosum in a Patient With Rheumatoid Arthritis with Prior use of Tumor Necrosis Factor Inhibitors: A Case Report and Review of the Literature. Mod Rheumatol Case Rep. 2022 Mar 12:rxac023. doi: 10.1093/mrcr/rxac023. Epub ahead of print. PMID: 35285489.
Ohkubo Y, Ohmura SI, Ishihara R, Miyamoto T. Transient Pneumonitis as a Possible Adverse Reaction to the BNT162b2 COVID-19 mRNA Vaccine in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature. Case Rep Rheumatol. 2022 Aug 23;2022:3124887. doi: 10.1155/2022/3124887. PMID: 36052104; PMCID: PMC9427306.
Yonezawa H, Ohmura SI, Ohkubo Y, Miyamoto T. New-onset SeropositiveRheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status. Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.0257-22. Epub ahead of print. PMID: 36070943.
Ohmura SI, Ohkubo Y, Ishihara R, Otsuki Y, Miyamoto T. Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination: A Case Report. Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.0293-22. Epub ahead of print. PMID: 36070946.
Ohkubo Y, Ohmura SI, Ishihara R, Miyamoto T. Possible case of polyarteritis nodosa with epididymitis following COVID-19 vaccination: A case report and review of the literature. Mod Rheumatol Case Rep. 2022 Oct 28:rxac085. doi: 10.1093/mrcr/rxac085. Epub ahead of print. PMID: 36305628; PMCID: PMC9620383.
Yonezawa H, Ohmura SI, Ohkubo Y, Otsuki Y, Miyamoto T. New-onset of Eosinophilic granulomatosis with polyangiitis without eosinophilia and eosinophilic infiltration under benralizumab treatment; a case report. Mod Rheumatol Case Rep. 2023 May 27:rxad028. doi:10.1093/mrcr/rxad028. Epub ahead of print. PMID: 37243733.
Ohmura SI, Yonezawa H, Yukishima T, Gohto Y, Obana A. New onset of giant Cell arteritis with ischaemic optic neuropathy following the seventh dose of COVID-19 mRNA vaccination: A case report and literature review. Mod Rheumatol Case Rep.2025 Jan 16;9(1):131-136. doi: 10.1093/mrcr/rxae042. PMID: 39096515.
Fukami S, Ohmura SI, Yukishima T, Hamada T, Otsuki Y, Ogawa N. Successful glucocorticoid treatment case for IgG4-related long-standing optic neuropathy. Mod Rheumatol Case Rep. 2025 Mar 6:rxaf015. doi: 10.1093/mrcr/rxaf015. Epub ahead of print. PMID: 40045599.
Yukishima T, Ohmura SI, Yonezawa H, Katayama M, Otsuki Y, Miyamoto T, Ogawa N. Possible usefulness of fluorodeoxyglucose positron emission tomography In diagnosing polyarteritis nodosa: A case report and literature review. Mod Rheumatol Case Rep. 2025 Jan 16;9(1):137-142. doi: 10.1093/mrcr/rxae044. PMID:39126149.
Yukishima T, Yonezawa H, Aono Y, Yamaguchi K, Otsuki Y, Ohmura SI. Successful switching treatment of mepolizumab for refractory eosinophilic granulomatosis with polyangiitis and multiple organ dysfunction under benralizumab treatment: A case report. Mod Rheumatol Case Rep. 2025 Jan 25:rxaf008. doi: 10.1093/mrcr/rxaf008. Epub ahead of print. PMID: 39856496.
Ohmura SI, Morishita N, Yonezawa H, Yukishima T, Ohkubo Y. Glucocorticoid sparing effect on Adalimumab for refractory Pyoderma gangrenosum in patients with Rheumatoid Arthritis: A Case series. Mod Rheumatol Case Rep. 2024 Dec 9:rxae075. doi: 10.1093/mrcr/rxae075. Epub ahead of print. PMID: 39657705.
Yukishima T, Ohmura SI, Yonezawa H, Ueyama A, Sato S, Katayama M, Ohkuma S, Otsuki Y, Ogawa N. Possible Case of Elderly-onset Intestinal Behçet's Disease with Trisomy 8 Following COVID-19 Vaccination Exacerbated by COVID-19 Infection.Intern Med. 2025 Jan 1;64(1):81-87. doi: 10.2169/internalmedicine.4197-24. Epub2024 Oct 18. PMID: 39428534; PMCID: PMC11781933.
Yukishima T, Ebina K, Etani Y, Noguchi T, Ohmura SI, Nakata K, Okada S,Kobayakawa T. Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies". Osteoporos Int. 2025 Mar 19. doi:
10.1007/s00198-025-07466-5. Epub ahead of print. PMID: 40108017.
